How—and Why—Two Big Law Attorneys Are Fighting to Destigmatize Psychedelics
This week's episode features a conversation between Law.com business of law reporter Dan Packel, Winston & Strawn associate Brett Waters and Katten Muchin Rosenman CEO Noah Heller. The topic? Psychedelics.
February 01, 2022 at 04:26 PM
2 minute read
This week's episode features a conversation between Law.com business of law reporter Dan Packel, Winston & Strawn associate Brett Waters and Katten Muchin Rosenman CEO Noah Heller. The topic? Psychedelics.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllHow My Postpartum Depression Led to Launching My Firm’s Parental Leave Coaching Program
9 minute readMany Lawyers Are Reeling From Election Results, but Leaders Are Staying Mum
6 minute readJudge: Schools Can Sue Social Media for Expenses Related to Addicted Students
5 minute readLaw Firms Mentioned
Trending Stories
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250